Cumberland Pharmaceuticals
Nasdaq CPIX · Nashville,, TN
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Respiratory
Cumberland Pharmaceuticals is a clinical trial sponsor based in Nashville,, TN, listed as Nasdaq CPIX. It has 2 active clinical trials with 162 planned participants, across 8 therapeutic areas. Since 2021 it has completed 6 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq CPIX
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 162 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 6 trials and stopped 1 early.
Cumberland Pharmaceuticals is based in Nashville,, TN and is listed as Nasdaq CPIX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Cumberland Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-02.
Approve Suite is not affiliated with Cumberland Pharmaceuticals.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.